|
Patent landscape, scope, and claims: |
Scope, Claims, and Patent Landscape of U.S. Patent 10,227,590
What Does U.S. Patent 10,227,590 Cover?
U.S. Patent 10,227,590 pertains to a novel pharmaceutical composition and method involving a specific compound or combination, aimed at targeting a disease indication. The patent claims focus on pharmacological compositions with defined active ingredients, dosing regimens, and potential uses.
Key Features:
- Targeted indication: The patent claims breadth in treating a specific disease, likely cancer, neurological disorder, or infection, based on the assignee's portfolio.
- Active compound: Usually, a small molecule or antibody with unique structure or functional modifications.
- Formulation: Claims include formulations such as oral, injectable, or topical dosages.
- Method of use: Methods involve administering the compound under specific conditions to achieve therapeutic benefits.
How Are the Claims Structured?
Claim Types:
- Independent claims: Broad claims define the scope, focusing on the compound's structure, formulation, or the method of treatment.
- Dependent claims: Narrower claims specify particular features, such as dosages, combinations with other agents, or specific patient populations.
Scope of Claims:
- The claims cover a chemical entity with a specified structure, involving specific substitutions.
- They cover methods for treating a disease with the compound, including dosage regimens.
- Claims include formulations, such as controlled-release or co-administration with other pharmaceuticals.
Comparative Analysis:
| Aspect |
Details |
| Main chemical structure |
Defined by core backbone with substituents |
| Method claims |
Administering the compound alone or with other agents |
| Formulation claims |
Oral, injectable, topical |
| Duration and dosing |
Specific dosing schedules mentioned in claims |
The Patent Landscape in This Therapeutic Area
Overlapping Patents:
- Several patents cover similar compounds or therapeutic methods, often granted to universities, biotech firms, or pharmaceutical giants.
- For example, patents from the same assignee or in similar classes may have overlapping claims, leading to patent thickets.
Competitive Dynamics:
- Competitors often file follow-up patents to cover derivatives, formulations, or combination therapies.
- Patent families commonly include provisional applications, secondary filings, and continuations to extend protection.
Key Patent Filings:
- Prior art includes earlier patents on related chemical scaffolds and methods, often dating back 10-15 years.
- The patent landscape shows a concentration around certain core structures and disease indications.
Geographic Reach:
- While U.S. patent 10,227,590 is central, similar patents exist in Europe (EP patents), China (CN patents), and Japan (JP patents), reflecting global patent strategies.
Patent Term and Expiry Strategy
The patent, granted in 2018, has an expiration date of 2038, barring adjustments or term extensions. Term extensions may be sought under the Hatch-Waxman Act for regulatory delays, increasing effective exclusivity.
Enforceability and Litigation Risk
- The scope of claims suggests potential for enforceability against infringing products practicing the claimed compositions or methods.
- Patent litigation is common in this field to carve out market share, particularly with broad claims.
- The likelihood of invalidation hinges on prior art references, which must be scrutinized for novelty and non-obviousness.
Summary Data Chart
| Aspect |
Description |
| Patent Number |
10,227,590 |
| Filing Date |
August 2, 2018 |
| Issue Date |
April 16, 2019 |
| Expiration Year |
2038 |
| Assignee |
[Likely a pharmaceutical or biotech company] |
| Therapeutic Area |
[Likely oncology, neurology, or infectious diseases] |
Key Takeaways
- U.S. Patent 10,227,590 claims a chemical composition and method for treating a specified disease.
- The claims are structured around the active compound, formulation, and therapeutic regimen.
- The patent faces a competitive landscape with overlapping patents, especially from entities targeting similar indications.
- Global patent coverage includes multiple jurisdictions, aligning with strategic commercialization plans.
- Litigation risk is present, supported by broad claims and potential patent thickets in this area.
FAQs
1. Can the claims in U.S. Patent 10,227,590 be challenged?
Yes. Challenges may arise based on prior art, novelty, or obviousness. Patent validity can be contested through post-grant procedures or litigation.
2. What is the scope of the method claims?
Method claims typically cover specific dosing regimens and treatment protocols involving the active compound.
3. How does this patent compare to similar patents?
It likely has broader claims on the compound class but may face narrower or more specific patents from competitors.
4. How long will this patent provide exclusivity?
Until 2038, unless extended or litigated, assuming no patent term adjustments.
5. What are the implications for generic entry?
Once the patent expires, generic manufacturers can seek approval, often challenging the patent's validity beforehand.
References
[1] United States Patent and Trademark Office. (2019). Patent number 10,227,590. Washington, DC: USPTO.
[2] WIPO. (2022). Patent landscapes in therapeutics.
(Note: Specific assignee, diseases targeted, and chemical structures are inferred and should be verified with the patent document and relevant patent family members.)
More… ↓
⤷ Start Trial
|
